Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal survival and growth, serves as a neurotransmitter modulator, and participates in neuronal plasticity, which is essential for learning and memory.
-
Oxidative stress is induced by an imbalanced redox states, involving either excessive generation of reactive oxygen species (ROS) or dysfunction of the antioxidant system.
-
Probiotics actively participate in neuropsychiatric disorders.
-
Magnesium is the fourth most abundant mineral in the body.
-
Recent studies suggest a possible link between type 2 diabetes and Alzheimer's disease (AD).
-
Alzheimer's disease (AD) and Parkinson's disease (PD) are devastating, frequent, and still incurable neurodegenerative diseases that manifest as cognitive and motor disorders.
-
Omega-3 polyunsaturated fatty acids (PUFAs) exhibit neuroprotective properties and represent a potential treatment for a variety of neurodegenerative and neurological disorders.
-
40/100
The aim of this paper is to provide a comprehensive review of the epidemiological evidence linking type 2 diabetes mellitus and its related conditions, including obesity, hyperinsulinemia, and metabolic syndrome, to Alzheimer's disease (AD).
-
Cholesterol is an essential component for neuronal physiology not only during development stage but also in the adult life.
-
Mushrooms have been consumed since earliest history; ancient Greeks believed that mushrooms provided strength for warriors in battle, and the Romans perceived them as the "Food of the Gods."
-
Advanced glycation end products (AGEs) consist of heterogenous group of macroprotein derivatives, which are formed by non-enzymatic reaction between reducing sugars and amino groups of proteins, lipids and nucleic acids, and whose process has progressed at an accelerated rate under diabetes.
-
Improvements in leptin and ghrelin levels following bariatric surgery appear to contribute to postoperative cognitive benefits.
-
The copper metabolism disorder Wilson's disease was first defined in 1912.
-
Recent studies indicate that glucagon-like peptide 1 (GLP-1) receptor agonists, currently used in the management of type 2 diabetes, exhibit neurotrophic and neuroprotective effects in amyloid-β (Aβ) toxicity models of Alzheimer's disease (AD).
-
Nutraceuticals are products, which other than nutrition are also used as medicine.
-
In the CNS, iron in several proteins is involved in many important processes such as oxygen transportation, oxidative phosphorylation, myelin production, and the synthesis and metabolism of neurotransmitters.
-
Protein misfolding and aggregation are associated with more than twenty diseases, such as neurodegenerative diseases and metabolic diseases.
-
Type 2 diabetes (T2D) and Alzheimer disease (AD) are two major health issues nowadays.
-
40/100
Tauroursodeoxycholic acid (TUDCA) is the taurine conjugate of ursodeoxycholic acid (UDCA), a US Food and Drug Administration-approved hydrophilic bile acid for the treatment of certain cholestatic liver diseases.
-
The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified and studied in the regulation of glycogen synthesis.
-
There has been much evidence demonstrating the involvement of oxidative stress in the pathology of neurological disorders.
-
Alzheimer's disease (AD) is an age-related neurodegenerative disease leading over the course of decades to the most common form of dementia.
-
The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide (GIP) have been developed to treat type 2 diabetes and also act as growth factors.
-
Type 2 diabetes is a risk factor in the development of Alzheimer's disease (AD).
-
Oxidative stress and mitochondrial damage have been implicated in the pathogenesis of several neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
From across this topic
10 of the 1,048 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- The gut-brain axis in Alzheimer's disease: early detection, microbial metabolites, mechanisms, and therapeutic opportunities
- Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease
- GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH
- Impact of intermittent fasting on health and disease processes
- Neurodegenerative diseases and oxidative stress
- BDNF and synaptic plasticity, cognitive function, and dysfunction
- Gut Microbiota is Altered in Patients with Alzheimer's Disease
- Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
- The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders
- Protein carbonyl groups as biomarkers of oxidative stress